Gastritis
📧 Sign up to get email alerts when something new happens for Gastritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology [Phase 4]
Phase 4 trial evaluating the effects of high-dose dual therapy and bismuth quadruple therapy for Helicobacter pylori eradication on intestin…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication [Phase 4]
Phase 4 study assessing the efficacy and safety of vonoprazan-based berberine triple therapy for first-line eradication of Helicobacter pylo…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing Vonorazon plus Amoxicillin dual therapy versus a bismuth-containing quadruple regimen for Helicobacter pylori-relate…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. [NA]
A pediatric trial update from Tashkent State Medical University describes developing rehabilitation methods for chronic gastroduodenal disea…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome Components
An Assiut University trial investigates the relationship between Helicobacter pylori-related gastritis and components of metabolic syndrome;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-31FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline …
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Blood Tests for Gastritis and Gastric Neoplasms
A completed clinical trial examining blood-based tests for detecting gastritis and gastric neoplasms has posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication [Phase 3]
Phase 3 trial comparing 7-day versus 14-day vonoprazan-based triple therapy for Helicobacter pylori eradication has completed.
-
FDA approval · 2024-11-12FDA Approved: CIMETIDINE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original application for cimetidine (generic cimetidine), authorizing its marketing as a generic H2 …
-
FDA approval · 2024-11-08FDA Approved: ACID REDUCER — Supplemental Application (WALGREEN CO.)
FDA approves a supplemental application for ACID REDUCER (omeprazole) from Walgreens Co., under ANDA206877.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
This clinical trial update shows the study evaluating the improvement of subjective symptoms with Mucotra SR Tablet in patients with gastrit…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori. [Phase 4]
Phase 4 clinical trial assessing a quadruple therapy of berberine, minocycline, esomeprazole, and colloidal bismuth for initial Helicobacter…
-
FDA approval · 2024-07-08FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the antibiotic combination Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochl…
-
FDA approval · 2024-07-08FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Winder Laboratories LLC)
FDA approved a generic version of the combination drug chlordiazepoxide hydrochloride and clidinium bromide from Winder Laboratories LLC. Th…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis [Phase 4]
Phase 4 clinical trial comparing Rebamipide/Nizatidine combination therapy to Nizatidine alone in patients with gastritis; the study has com…
-
FDA approval · 2024-05-28FDA Approved: FAMOTIDINE — Original Application (LEADER/ Cardinal Health 110, Inc.)
FDA approved the original ANDA for famotidine from LEADER/ Cardinal Health 110, Inc., providing a generic version of famotidine.
-
FDA approval · 2024-01-17FDA Approved: SUCRALFATE — Original Application (TruPharma, LLC)
FDA approves the original application for sucralfate oral by TruPharma, LLC.
-
FDA approval · 2023-09-14FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original A…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) [NA]
Clinical trial MAGNET evaluating magnetically controlled capsule for gastric mucosa assessment has completed with results posted; conditions…
-
FDA approval · 2023-07-18FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA granted supplemental approval for a lansoprazole-amoxicillin-clarithromycin combination product by Rising Pharma Holdings, Inc. to e…
-
FDA approval · 2023-05-25FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for the fixed-dose combination of chlordiazepoxide hydrochloride and clidinium bromide (Librax) …
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis [Phase 2]
Phase 2 trial reporting efficacy and safety of Houtou Jianweiling Tablet for chronic non-atrophic gastritis has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention [Phase 4]
Phase 4 clinical trial assessing ALBIS for protection against gastroduodenal mucosal injury in patients on dual antiplatelet therapy after P…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing berberine plus amoxicillin triple therapy to bismuth-containing quadruple therapy for Helicobacter pylori eradicatio…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication [Phase 4]
Phase 4 trial assessing the efficacy and safety of berberine-containing triple therapy for first-line eradication of Helicobacter pylori and…